CVE-2007-1322

Description

QEMU 0.8.2 allows local users to halt a virtual machine by executing the icebp instruction.

2.1
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.11%
Vendor Advisory debian.org Vendor Advisory mandriva.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/34043 vdb entry third party advisory
http://www.securityfocus.com/bid/23731 vdb entry third party advisory
http://www.debian.org/security/2007/dsa-1284 third party advisory vendor advisory
http://secunia.com/advisories/25073 third party advisory
http://taviso.decsystem.org/virtsec.pdf third party advisory technical description
http://www.mandriva.com/security/advisories?name=MDVSA-2008:162 third party advisory vendor advisory
http://osvdb.org/35496 vdb entry broken link
http://www.vupen.com/english/advisories/2007/1597 vdb entry third party advisory
http://secunia.com/advisories/29129 third party advisory
http://secunia.com/advisories/25095 third party advisory

Frequently Asked Questions

What is the severity of CVE-2007-1322?
CVE-2007-1322 has been scored as a low severity vulnerability.
How to fix CVE-2007-1322?
To fix CVE-2007-1322, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2007-1322 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2007-1322 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.